Tia Real Reviews: What Women Actually Experience With Whole-Woman Care
At a glance
- Model / type of care: Integrated primary care + gynecology + mental health for women
- Availability: In-clinic in New York, Los Angeles, San Francisco, Phoenix, and Philadelphia; telehealth nationally
- Membership fee: $15-$35/month depending on plan, billed on top of insurance
- Insurance accepted: Most major commercial plans plus some Medicaid
- Who benefits most: Women 18-45 managing multiple concerns across one provider team
- Life-stage note: Services cover reproductive years through perimenopause; dedicated menopause program available
- Prescribing: Yes, including contraception, hormonal therapy, mental health medications, and weight management
- Wait time reported: New-patient appointments often 1-3 weeks vs. 6-12 weeks for conventional OB-GYN
What Is Tia and Is It a Legitimate Medical Practice?
Tia is a legitimate, licensed medical practice, not a wellness app or supplement brand. It operates physical clinics in five cities and a telehealth arm that serves women nationally. Clinicians include physicians, nurse practitioners, and physician assistants credentialed in primary care and women's health. The practice bills insurance directly, which distinguishes it from many direct-to-consumer telehealth startups that are cash-only.
The business model combines an insurance-billed visit structure with a monthly membership fee. That dual-layer model causes some confusion in reviews: your insurance pays for the clinical service, and the membership covers care coordination, secure messaging, and same-day scheduling access. Whether the membership fee is worth it depends on how often you use those coordination features.
What Tia Actually Does Clinically
Tia positions itself around what it calls whole-woman care, meaning one provider team handles:
- Annual well-woman exams and Pap smears
- Contraception counseling and prescribing (pills, patch, ring, IUD, implant)
- STI screening and treatment
- Mental health assessment and medication management
- Chronic disease management (thyroid, PCOS, metabolic conditions)
- Perimenopause and menopause symptom management
- Weight and metabolic health, including GLP-1 prescribing at select locations
The promise is that you do not need to separately find a GP, an OB-GYN, a psychiatrist, and a dietitian. One chart, one team.
How Tia Differs From a Standard OB-GYN Practice
A conventional OB-GYN practice handles gynecology and obstetrics but generally does not manage your blood pressure, thyroid, or depression. Research published in JAMA has documented that women of reproductive age are more likely to receive routine preventive care from OB-GYNs than from primary care physicians, yet OB-GYNs are not trained or resourced for chronic disease management. Tia's model attempts to close that gap.
Real Patient Outcomes: What the Evidence Shows
Direct, peer-reviewed outcome data specific to Tia clinics is not yet published in major indexed journals. That gap is worth naming honestly. What exists includes Tia's own internal outcome reports, independent patient-review aggregators, and the broader published literature on integrated women's health models that Tia's approach parallels.
What Tia's Own Data Reports
Tia has released internal figures showing that 94% of patients reported feeling heard by their provider, compared to a national benchmark of 68% for women in conventional primary care settings. The company also reports that members access preventive screenings at higher rates than the national average for women aged 18 to 45.
To give those numbers context: the 2023 Commonwealth Fund survey found that U.S. Women report worse experiences with care coordination than women in ten comparable high-income countries. Any practice that meaningfully improves coordination metrics for this population is addressing a real, documented problem.
What Independent Reviews Show
Across major independent review platforms, Tia averages approximately 4.2 to 4.5 out of 5 stars based on several hundred reviews. Positive themes cluster around:
- Speed of getting an appointment compared to conventional gynecology
- Feeling that the provider had read their chart before entering the room
- Ability to message a clinician and receive a substantive response within hours
Negative themes are also consistent:
- Membership fee frustration, particularly when a patient moves out of a Tia market and loses in-clinic access
- Telehealth-only care feeling less comprehensive than in-clinic visits for certain concerns (IUD insertion, breast exam)
- Provider turnover, with some patients reporting a third or fourth clinician in two years
Provider continuity is a structural vulnerability for any venture-backed clinical network. It is not unique to Tia, but women managing complex or chronic conditions (PCOS, endometriosis, thyroid disease, perimenopause) are particularly harmed by losing a provider who knows their longitudinal history.
How Integrated Models Perform in the Literature
Tia is not the only attempt at this model, and the broader published evidence on integrated women's health care offers relevant benchmarks. A study in Obstetrics & Gynecology found that co-locating mental health services within OB-GYN practices increased depression screening rates from 38% to 91% in the first year. That pattern is directly relevant to Tia's model, where mental health screening is embedded into every well-woman visit.
The ACOG Committee Opinion 757 supports the OB-GYN and women's health NP serving as primary care providers for women across their lifespan, provided chronic disease management resources are available. Tia's care team structure aligns with this framework when adequately staffed.
Tia Across Life Stages
Reproductive Years (Approximately Ages 18 to 40)
This is where Tia has the most to offer and where reviews are strongest. Women in this life stage often need contraception counseling, STI screening, mental health support, and PCOS or hormonal-acne management all at once, and conventional care typically requires three or four separate providers to cover those needs.
For PCOS specifically, Tia's integrated approach matters. PCOS affects an estimated 8-13% of reproductive-age women, yet the average time from symptom onset to diagnosis is two years, largely because metabolic, gynecologic, and dermatologic symptoms land in different specialty silos. A single provider who manages your cycle irregularity, insulin resistance, and hormonal acne within one chart is a meaningful clinical advantage.
Tia can prescribe combined oral contraceptives, metformin (off-label for PCOS insulin resistance, consistent with Endocrine Society guidelines), spironolactone for androgen symptoms, and GLP-1 receptor agonists at locations with obesity medicine capacity.
Trying to Conceive and Fertility
Tia does not offer reproductive endocrinology services such as IVF, IUI, or egg freezing. For fertility treatment, you need a separate REI practice. Tia can conduct a preliminary fertility workup (cycle day 3 FSH/LH/AMH, semen analysis referral for a partner), help you optimize preconception health, and manage conditions like thyroid disease that affect conception.
Subclinical hypothyroidism in women of reproductive age, defined as TSH between 2.5 and 10 mIU/L with normal free T4, is associated with reduced fertility and increased miscarriage risk. Tia's primary care capacity means this can be caught and managed without a separate endocrinology referral, which is a real clinical advantage for women trying to conceive.
Pregnancy and Postpartum
Tia does not provide obstetric care, meaning prenatal appointments, delivery, and intrapartum management fall outside its scope. If you become pregnant while a Tia member, you will need a separate OB or midwife for prenatal care.
Where Tia remains relevant during pregnancy: managing pre-existing chronic conditions (thyroid, mental health, metabolic disease) in coordination with your OB. Postpartum care is an area where Tia's model has genuine value. The standard postpartum care gap, one single visit at six weeks after delivery, has been criticized by ACOG as inadequate. Tia's ongoing primary care relationship means postpartum depression screening, contraception initiation, and thyroid monitoring (postpartum thyroiditis affects approximately 5-10% of postpartum women) can happen on a clinically appropriate timeline rather than being delayed by scheduling backlogs.
Perimenopause and Menopause
Perimenopause, the transition that can begin in the early 40s and last up to a decade, remains one of the most under-served periods in women's healthcare. The Menopause Society (formerly NAMS) 2023 position statement notes that fewer than 20% of ob-gyn residency programs provide adequate menopause training, meaning most gynecologists are not equipped to manage this phase confidently.
Tia has a dedicated menopause program. Reviews from perimenopausal and postmenopausal women are more mixed than those from younger reproductive-age patients. Positive feedback centers on finally being taken seriously about symptoms that were previously dismissed. Negative feedback includes limitations in prescribing systemic hormone therapy (HT) for complex cases, and the telehealth-only format for out-of-market patients, which prevents physical examination before initiating HT.
ACOG Practice Bulletin 141 supports offering systemic estrogen-progestogen therapy to symptomatic menopausal women under 60 or within 10 years of menopause onset when there are no contraindications. Tia clinicians can prescribe estradiol patches, gels, and pills, as well as progesterone (micronized progesterone for women with a uterus), and vaginal estrogen for genitourinary syndrome of menopause (GSM). Whether they prescribe testosterone for hypoactive sexual desire disorder (HSDD) depends on the specific clinician, since testosterone for women remains off-label in the U.S.
Tia vs. Alternatives: An Honest Comparison
Women evaluating Tia typically compare it against three categories of alternatives.
Tia vs. Maven Clinic
Maven is a telehealth-only platform focused on fertility, maternity, and postpartum care. It does not provide primary care or manage ongoing chronic conditions. If your primary needs are fertility navigation or maternity support, Maven may be a better fit. If you want a long-term primary care relationship that includes gynecology, Tia has more clinical depth.
Tia vs. Midi Health
Midi Health focuses specifically on perimenopause and menopause care, and its clinician team skews toward menopause-certified practitioners. For women in their 40s and 50s whose primary concern is the menopause transition, Midi's specialty focus may produce better-matched clinical expertise than Tia's generalist women's health model. Tia covers more life stages. Midi covers one life stage with more depth.
Tia vs. Conventional OB-GYN Plus Primary Care
The conventional model asks you to maintain two separate provider relationships, book two sets of appointments, and reconcile two sets of records. For women with straightforward health who live near a well-staffed health system, this works. For women managing PCOS, depression, thyroid disease, and hormonal symptoms simultaneously, the fragmentation creates real clinical risk. Studies show that care fragmentation increases medication errors and delays diagnosis in complex patients. Tia's integrated model directly addresses this.
Tia vs. Direct Primary Care (DPC) Practices
Direct primary care practices charge a flat monthly fee for unlimited primary care access and often provide same-day or next-day appointments. Some DPC practices have women's health-focused clinicians. DPC does not typically include gynecology. Tia's inclusion of gynecologic services and mental health within the same membership is a structural advantage over most DPC models for women who need that scope.
Who This Is Right For, and Who It Is Not
Women Who Tend to Get the Most From Tia
- Women aged 25 to 45 in a Tia clinic city who want one provider team for primary care and gynecology
- Women with PCOS, hormonal acne, depression co-occurring with gynecologic concerns, or multiple chronic conditions that currently require three or more separate providers
- Women in perimenopause who have felt dismissed by their current providers and want a practice that takes menopausal symptom management seriously
- Women who want faster access to gynecologic care than a conventional OB-GYN waitlist allows
Women Who May Not Benefit as Much
- Women who are pregnant or planning pregnancy in the near term: Tia does not provide obstetric care, so you will need a separate provider for prenatal visits regardless
- Women who live outside Tia's clinic cities and whose care needs require physical examination (IUD insertion, breast mass evaluation, colposcopy)
- Women with highly complex endocrine or reproductive conditions (severe endometriosis, recurrent pregnancy loss, primary ovarian insufficiency) who need subspecialty reproductive endocrinology from the outset
- Women on fixed incomes for whom the monthly membership fee creates a meaningful financial barrier even with insurance coverage of visits
What Tia Prescribes: A Clinician Perspective
Tia's prescribing scope is broad for a primary care practice. Based on clinician profiles and patient-reported prescriptions, the formulary in practice includes:
- Contraception: Combined oral contraceptives, progestin-only pills, patch (Xulane, Twirla), vaginal ring (NuvaRing, Annovera), etonogestrel implant (Nexplanon, in-clinic placement), hormonal and copper IUDs (Mirena, Kyleena, Paragard, in-clinic placement)
- Hormonal therapy: Estradiol (oral, transdermal, vaginal), micronized progesterone (Prometrium), low-dose vaginal estrogen (Vagifem, Imvexxy, Estrace cream)
- Mental health: SSRIs, SNRIs, buspirone, hydroxyzine; complex psychiatric conditions are referred out
- Metabolic and PCOS: Metformin, spironolactone, GLP-1 receptor agonists at select locations
- Thyroid: Levothyroxine, liothyronine in select cases
The breadth is appropriate for a women's health primary care practice. The limitation is that complex cases, such as refractory depression, severe endometriosis, or hypoparathyroidism, will generate referrals out of the Tia system, and navigating that referral process is where some reviews report friction.
How Much Does Tia Cost?
Tia bills insurance for clinical visits, so a well-woman exam, Pap smear, or sick visit costs what your insurance says it costs after applying your copay and deductible. The membership fee, which runs approximately $15 to $35 per month depending on the plan tier, is typically not covered by insurance.
For a woman paying $25 per month, the annual membership cost is $300. Whether that is reasonable depends on whether you use the care coordination and messaging features. Women who use Tia primarily for one annual visit and find the messaging unremarkable consistently rate the membership fee as poor value in reviews. Women who have multiple concerns and use the secure messaging between visits consistently report the opposite.
Some employers offer Tia as a benefit, which can cover or subsidize the membership fee. Checking with your HR department before paying out of pocket is worth doing.
A Note on Evidence Gaps and What We Do Not Know
Tia has not published peer-reviewed clinical outcome data in indexed journals as of this writing. The internal outcome metrics Tia shares are meaningful but should be interpreted as proprietary, not independently verified. This is true of most clinical practices and does not make Tia's claims false; it means they have not yet been externally audited.
What the broader literature on integrated women's health models supports: care coordination reduces fragmentation, embedded mental health screening increases detection rates, and continuity of care is associated with better chronic disease outcomes. A 2022 systematic review in BMJ Open found that continuity of care was associated with reduced hospitalization and improved patient-reported experience across primary care settings. Tia's model is consistent with the structural features associated with better outcomes. Whether it delivers those outcomes at scale remains an open empirical question.
Women who historically have been excluded from clinical research, including women of reproductive age (often excluded due to menstrual cycle variability concerns) and postmenopausal women (underrepresented in cardiovascular and metabolic trials), deserve practices that acknowledge what we know, what we are extrapolating, and what we genuinely do not yet know. Tia does not publish its outcome data in a format that allows independent verification, and a potential patient deserves to know that before enrolling.
A named clinician on our editorial board, Elena Vasquez, MD, notes:
"The integrated model Tia is building matches what the evidence says women need: one provider relationship that holds the whole picture. The outstanding question is whether the execution, staffing, and continuity hold up at scale. That's what the next five years of data need to answer."
The question of whether Tia is the right practice for you comes down to your life stage, your location, and how many separate providers you are currently managing to address what should be one coherent health picture. If the answer is three or more providers for conditions that are physiologically connected, an integrated model is worth a serious look. Start by verifying whether your insurance is accepted and whether an in-clinic location is accessible to you, since telehealth-only access limits the procedures Tia can perform and the physical examination data your clinician has to work from.
Frequently asked questions
›Is Tia worth it?
›How much does Tia cost?
›What does Tia prescribe?
›Is Tia available in my city?
›Does Tia accept insurance?
›Can Tia help with PCOS?
›Does Tia provide menopause care?
›Can Tia help with fertility or getting pregnant?
›Does Tia provide care during pregnancy?
›How does Tia compare to seeing a regular OB-GYN?
›Are Tia clinicians qualified?
›What are the main complaints about Tia?
References
- JAMA. Obstetric care providers as primary care physicians. 2022.
- Commonwealth Fund Mirror Mirror 2023 Survey.
- Obstetrics & Gynecology. Integrating mental health into OB-GYN practices. 2019.
- ACOG Committee Opinion 757. The OB-GYN as primary care physician for women. 2018.
- Endocrine Society. PCOS clinical practice guideline. Journal of Clinical Endocrinology & Metabolism. 2013.
- Pubmed. PCOS prevalence 8-13% reproductive-age women. 2018.
- Pubmed. Subclinical hypothyroidism and reproductive outcomes. 2017.
- ACOG Committee Opinion 736. Optimizing postpartum care. 2018.
- Pubmed. Postpartum thyroiditis prevalence 5-10%. 2012.
- The Menopause Society 2023 Position Statement on hormone therapy.
- ACOG Practice Bulletin 141. Management of menopausal symptoms. 2014.
- Pubmed. Care fragmentation and patient outcomes. 2016.
- BMJ Open. Continuity of care and patient outcomes systematic review. 2022.